Executive Summary India has emerged as a major force in the global pharmaceutical industry, supported by its extensive manufacturing infrastructure, technical expertise and strong presence acros...
ChrysCapital to Acquire Linux Laboratories Stake The Story: ChrysCapital is set to acquire a 20–25% stake in CNS-focused Linux Laboratories for around ₹600 crore, with Tata Capital Healthcare Fund II ...
Key Highlights: Implications: The new cGMP/US FDA/EU-compliant suite at Gland’s Visakhapatnam JNPC site, adding ~1,400 kg/year of sterile API capacity, should help both companies capture m...
Key Highlights: Implications: By adding the NSE to its existing BSE listing, Fermenta can attract more institutional and retail participation, which may support tighter spr...
Key Highlights: Implications:The restructuring positions RPG Life Sciences to build a more focused and scalable API platform by separating the business from its formulations operations and backing it ...
Key Highlights: Implications: GTBL’s MicroBiopharm acquisition is a strategic move to become a more integrated, higher-value pharma services and ingredients player. The mai...
Key Highlights: Implications: Obeda gives Dr. Reddy’s a second GLP‑1 foothold in India, but this time in the much bigger day‑to‑day diabetes market, not just injectable semaglutide. Because it ...
Latest Developments in Global Pharma Supply Chains The COVID-19 pandemic exposed critical vulnerabilities in global pharmaceutical supply chains, highlighting the risks associated with overrelia...
Key Highlights: Implications: HRV Pharma is using the Shodhana alliance to turn its AI‑enabled “Virtual API” model into tangible, regulated assets, starting with a pharmaceutical...
